Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Affective Disorders Reports|July 21, 2023
Adverse events in older adults and the risk of dementia and cognitive declineDinuli Nilaweera, Caroline Gurvich, Rosanne Freak-Poli, et al.BMC Neurology|February 10, 2012
Aspirin for the prevention of cognitive decline in the elderly: rationale and design of a neuro-vascular imaging study (ENVIS-ion)Christopher M Reid, Elsdon Storey, Tien Y Wong, et al.The Medical Journal of Australia|March 6, 2019
Recruiting general practice patients for large clinical trials: lessons from the Aspirin in Reducing Events in the Elderly (ASPREE) studyJessica E Lockery, Taya A Collyer, Walter P Abhayaratna, et al.Age and Ageing|April 5, 2026
Trajectories of frailty, grip strength and gait speed preceding dementia: a nested case-control studyZimu Wu, Aung Zaw Zaw Phyo, Lachlan Cribb, et al.The Medical Journal of Australia|July 22, 2008
Feasibility of conducting a primary prevention trial of low-dose aspirin for major adverse cardiovascular events in older people in Australia: results from the ASPirin in Reducing Events in the Elderly (ASPREE) pilot studyMark R Nelson, Christopher M Reid, David A Ames, et al.Age and Ageing|September 25, 2025
The effect of low-dose aspirin on reversing frailty status in older prefrail and frail adults: a secondary analysis of the ASPREE randomised clinical trialAnanta P Handono, Joanne Ryan, Fajar Setiawan, et al.Contemporary Clinical Trials Communications|July 25, 2017
Age-related macular degeneration in a randomized controlled trial of low-dose aspirin: Rationale and study design of the ASPREE-AMD studyLiubov Robman, Robyn Guymer, Robyn Woods, et al.Journal of Hypertension|August 3, 2020
Impact of the 2017 American Heart Association and American College of Cardiology hypertension guideline in aged individualsEnayet Karim Chowdhury, Michael E Ernst, Mark Nelson, et al.Pageof 2